Cargando…
A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma
OBJECTIVES: Herein, we purposed to establish and verify a competing risk nomogram for estimating the risk of cancer-specific death (CSD) in Maxillary Sinus Carcinoma (MSC) patients. METHODS: The data of individuals with MSC used in this study was abstracted from the (SEER) Surveillance, Epidemiology...
Autores principales: | Hu, Mingbin, Li, Xiancai, Gu, Weiguo, Mei, Jinhong, Liu, Dewu, Chen, Shaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421678/ https://www.ncbi.nlm.nih.gov/pubmed/34504784 http://dx.doi.org/10.3389/fonc.2021.698955 |
Ejemplares similares
-
Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis
por: Li, Xiancai, et al.
Publicado: (2021) -
Based on clinical Ki-67 expression and serum infiltrating lymphocytes related nomogram for predicting the diagnosis of glioma-grading
por: Zhang, Zhi, et al.
Publicado: (2022) -
Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review
por: Hu, Mingbin, et al.
Publicado: (2022) -
Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma
por: Gu, WeiGuo, et al.
Publicado: (2020) -
The Ki-67 Proliferation Index-Related Nomogram to Predict the Response of First-Line Tyrosine Kinase Inhibitors or Chemotherapy in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor-Mutant Status
por: Gu, Weiguo, et al.
Publicado: (2021)